Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Cash from Financing Activities (2022 - 2026)

Centessa Pharmaceuticals has reported Cash from Financing Activities over the past 4 years, most recently at $283.4 million for Q4 2025.

  • Quarterly Cash from Financing Activities rose 9464.63% to $283.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $291.5 million through Dec 2025, down 20.08% year-over-year, with the annual reading at $291.5 million for FY2025, 20.08% down from the prior year.
  • Cash from Financing Activities was $283.4 million for Q4 2025 at Centessa Pharmaceuticals, up from $3.4 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $283.4 million in Q4 2025 and troughed at $12000.0 in Q2 2023.
  • The 4-year median for Cash from Financing Activities is $3.1 million (2025), against an average of $45.2 million.
  • Year-over-year, Cash from Financing Activities surged 877508.33% in 2024 and then plummeted 98.6% in 2025.
  • A 4-year view of Cash from Financing Activities shows it stood at $89000.0 in 2022, then surged by 7047.19% to $6.4 million in 2023, then crashed by 53.42% to $3.0 million in 2024, then soared by 9464.63% to $283.4 million in 2025.
  • Per Business Quant, the three most recent readings for CNTA's Cash from Financing Activities are $283.4 million (Q4 2025), $3.4 million (Q3 2025), and $1.6 million (Q2 2025).